Education
About Us
Working with TipRanks
Follow Us
Dr. Lal PathLabs Limited (IN:LALPATHLAB)
:LALPATHLAB
RESEARCH TOOLSreports
Total Valuation
Dr. Lal PathLabs Limited has a market cap or net worth of ₹247.47B. The enterprise value is ₹85.15B.
Market Cap₹247.47B
Enterprise Value₹85.15B
Share Statistics
Dr. Lal PathLabs Limited has 83,775,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding83,775,510
Owned by Insiders―
Owned by Institutions0.08%
Financial Efficiency
Dr. Lal PathLabs Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 38.44%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)38.44%
Return on Capital Employed (ROCE)0.50
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.91
Inventory Turnover26.70
Valuation Ratios
The current PE Ratio of Dr. Lal PathLabs Limited is 41.09. Dr. Lal PathLabs Limited’s PEG ratio is 1.08.
PE Ratio41.09
PS Ratio0.00
PB Ratio10.28
Price to Fair Value9.21
Price to FCF39.79
Price to Operating Cash Flow35.52
PEG Ratio1.08
Income Statement
In the last 12 months, Dr. Lal PathLabs Limited had revenue of 24.61B and earned 4.87B in profits. Earnings per share was 58.48.
Revenue24.61B
Gross Profit14.97B
Operating Income11.56B
Pretax Income6.25B
Net Income4.87B
EBITDA6.96B
Earnings Per Share (EPS)58.48
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Dr. Lal PathLabs Limited pays an annual dividend of ₹24, resulting in a dividend yield of 0.81%
Dividend Per Share₹24
Dividend Yield0.81%
Payout Ratio9.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change9.35%
50-Day Moving Average2.77K
200-Day Moving Average2.92K
Relative Strength Index (RSI)66.32
Average Volume (3m)4.89K
Important Dates
Dr. Lal PathLabs Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 25, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateJun 06, 2025
Financial Position
Dr. Lal PathLabs Limited as a current ratio of 3.39, with Debt / Equity ratio of 13.35%
Current Ratio3.39
Quick Ratio3.30
Debt to Market Cap0.00
Net Debt to EBITDA-0.98
Interest Coverage Ratio51.83
Taxes
In the past 12 months, Dr. Lal PathLabs Limited has paid 1.32B in taxes.
Income Tax1.32B
Effective Tax Rate0.21
Enterprise Valuation
Dr. Lal PathLabs Limited EV to EBITDA ratio is 27.80, with an EV/FCF ratio of 36.86.
EV to Sales7.85
EV to EBITDA27.80
EV to Free Cash Flow36.86
EV to Operating Cash Flow33.99
Balance Sheet
Dr. Lal PathLabs Limited has ₹11.65B in cash and marketable securities with ₹1.57B in debt, giving a net cash position of -₹10.08B billion.
Cash & Marketable Securities₹11.65B
Total Debt₹1.57B
Net Cash-₹10.08B
Net Cash Per Share-₹120.32
Tangible Book Value Per Share₹168.72
Margins
Gross margin is 57.44%, with operating margin of 46.96%, and net profit margin of 19.79%.
Gross Margin57.44%
Operating Margin46.96%
Pretax Margin25.38%
Net Profit Margin19.79%
EBITDA Margin28.26%
EBIT Margin22.49%
Analyst Forecast
The average price target for Dr. Lal PathLabs Limited is ₹3,107.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹3,107.50
Price Target Upside6.91% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―